Hundreds of Los Angeles fire victims received some heavy, cuddly, and lifesaving mental health support on Monday from a ...

Most people with Duchenne muscular dystrophy (DMD) develop heart problems by adulthood, making management of cardiac health ...

Lucy Smith, 23, from Dumfries and Galloway, thought she was burnt out from working long hours as a carer when in reality she ...

Tenaya intends to use the net proceeds from the offering to fund the ongoing and planned development of its clinical and ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...

Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...

A week after the gruelling operation her family was told to prepare to lose Lucy as her body was showing signs of rejecting ...

Scotiabank raised the firm’s price target on Rocket Pharmaceuticals (RCKT) to $52 from $51 and keeps an Outperform rating on the shares. The ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...

Pratteln, Switzerland, March 4, 2025 – Santhera Pharmaceuticals (SIX: SANN) today provides a trading update for the fiscal year 2024 and an outlook for 2025 and beyond.

The initial clinical assessments elicited stark awareness of a syndromic condition of varied causes (originally rheumatic heart disease, hypertension, and coronary disease) characterized by abysmal ...

LeerinkGlobal Biopharma Conference: Robert I. Blum, President and Chief Executive Officer, and Andrew Callos, Executive Vice President and Chief Commercial Officer, will participate in a fireside chat ...